---
category: news
title: "One Key to Pandemic Retailing: Artificial Intelligence"
excerpt: "Retail is no stranger to artificial intelligence. Nearly a decade ago ... Gilead Sciences won approval for remdesivir as an anti-Covid therapy. With the election looming, House Speaker Nancy Pelosi set a Tuesday deadline to reach a deal on Covid relief."
publishedDateTime: 2020-10-24T04:07:00Z
originalUrl: "https://www.barrons.com/articles/one-key-to-pandemic-retailing-artificial-intelligence-51603500768"
webUrl: "https://www.barrons.com/articles/one-key-to-pandemic-retailing-artificial-intelligence-51603500768"
ampWebUrl: "https://www.barrons.com/amp/articles/one-key-to-pandemic-retailing-artificial-intelligence-51603500768"
cdnAmpWebUrl: "https://www-barrons-com.cdn.ampproject.org/c/s/www.barrons.com/amp/articles/one-key-to-pandemic-retailing-artificial-intelligence-51603500768"
type: article

provider:
  name: Barron's
  domain: barrons.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://images.barrons.com/im-248999/social"
    width: 1280
    height: 640
    isCached: true

secured: "o/WX5n7F4TsludxRzs5OX/+iv5S91QDBELpB97kRWND6zGBC+S+eMLftMYfvLPifrAtQwENRa/4o7PHJM09A4wG0wLqHslZKjhB+RhAoMHTfUVHWpnG3hAUdchxw9Muuxe0mpfo/4Wtvcd6fSafWGJ3b6/91wbs/UCeWP7wGd5VP3+zESqbSkde/S6HzEVoB5JARU3EBhRb/wAkEQ4VdO5vYzguFU67lKdK0NpSKkQJ8I+LnKudK78J2uAQxesmIh6xjaNvtcIcJsqNHbG1PUVdjeGWyGZNf7e0JxKcd+ViLumqqXgNDUzDTIGj8xCr4mbcvxV6CYBPktHVxh9a026vLxTx/88qthkVvR4XOsBs=;L1j/n/UicvrOgqKSe1MIOQ=="
---

